Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Use of Computers for Processing Medical Bills to Be Promoted
February 18, 2002
- Marketing Suspension of Berotec Aerosol Requested by Medwatcher Japan
February 18, 2002
- JMA Committee Opposed to Increases in Copayment
February 18, 2002
- New System to Widen Gaps between Generic Houses: EMA President
February 18, 2002
- Top Priority Should Be Put on Pharmaceutical Education Reform: JSHP President
February 18, 2002
- 4 Companies Form Group to Promote Generics
February 18, 2002
- Terumo: Consolidated 3rd Qtr Sales Total \49,772 Mil.
February 18, 2002
- WEBSITE NEWS
February 18, 2002
- J-Phone Develops New System Directly Transferring Images to Mobile Phone
February 18, 2002
- BUSINESS NEWS IN BRIEF
February 18, 2002
- Medical Device Federation Requests Regulatory Reforms
February 18, 2002
- FDA Is Very Interested in Immediate PMS System: Dr Kurokawa of PFSB
February 18, 2002
- Korosho to Accept STED-based Applications for Medical Devices
February 18, 2002
- Korosho to Allow Hospitals to Charge Special Medical Treatment Fee for Unlisted Drugs
February 18, 2002
- Court Rejects Taisho's Demands in Lawsuit Against Daikoku
February 18, 2002
- Legal Drug Classification to Be Revised
February 18, 2002
- 49% Rise in Operating Profits Expected for Ain Pharmaciez: Nomura Report
February 18, 2002
- EAD Director Calls on Makers to Reduce Invoice Prices
February 18, 2002
- Sugi Pharmacy's Ordinary Profits to Jump 40%: Okasan Securities
February 18, 2002
- Safety Measures Must Be Coordinated with Global Standards: Korosho Official
February 18, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…